Access the full text.
Sign up today, get DeepDyve free for 14 days.
John Elsenberg, Siariley Goldfarb (1976)
Clinical usefulness of measuring prothrombin time as a routine admission test.Clinical chemistry, 22 10
A. Suchman, P. Griner (1986)
Diagnostic uses of the activated partial thromboplastin time and prothrombin time.Annals of internal medicine, 104 6
Erban Erban, Kinman Kinman, Schwartz Schwartz (1989)
Routine use of the prothrombin and partial thromboplastin timesJAMA, 262
J. Robbins, S. Rose (1979)
Partial thromboplastin time as a screening test.Annals of internal medicine, 90 5
J. Eisenberg, J. Clarke, S. Sussman (1982)
Prothrombin and partial thromboplastin times as preoperative screening tests.Archives of surgery, 117 1
Eika Eika, Havig Havig, Godal Godal (1979)
The value of preoperative hemostatic screeningScand J Haematol, 8
E. Rader (1978)
Hematologic screening tests in patients with operative prostatic disease.Urology, 11 3
Suchman Suchman, Mushlin Mushlin (1986)
How well does the activated partial thromboplastin time predict postoperative hemorrhageJAMA, 256
M. Rohrer, M. Michelotti (1988)
A Prospective Evaluation of the Efficacy of Preoperative Coagulation TestingAnnals of Surgery, 208
Prothrombin time and partial thromboplastin time tests are commonly obtained prior to cardiac catheterization but the usefulness of the tests in these patients has not been examined. The records of 1,462 consecutive patients undergoing diagnostic catheterization were reviewed. All patients had received prothrombin time and partial thromboplastin time tests. The prevalence of abnormal test values was determined. The coagulation test values were correlated with history and physical evidence of bleeding risk, and also with bleeding complications. Abnormal coagulation values were found in 72/1,462, a prevalence of 4.9%. The history and physical exam predicted 63/72 (87.5%) of abnormal values, yielding a sensitivity of 87.5%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 99.3%. The nine unpredicted abnormal values (0.6%, 9/1,462) were minimally abnormal and clinical decision making was not affected by the test result in any of the nine patients. There was no correlation between abnormal values and bleeding complications. Abnormal test values have a low prevalence in catheterization patients, 4.9% in this series, are highly predictable from history and physical exams, and in the absence of history or physical findings do not predict procedural bleeding complications. The tests should, therefore, be obtained only in a small percentage of patients, 4.3% in this series, who have an increased bleeding risk indicated by history or physical findings of anticoagulant use, excessive bleeding, liver disease, or malabsorption.
Journal of Interventional Cardiology – Wiley
Published: Mar 1, 1990
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.